International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

  1. Dombret, H.
  2. Seymour, J.F.
  3. Butrym, A.
  4. Wierzbowska, A.
  5. Selleslag, D.
  6. Jang, J.H.
  7. Kumar, R.
  8. Cavenagh, J.
  9. Schuh, A.C.
  10. Candoni, A.
  11. Récher, C.
  12. Sandhu, I.
  13. Del Castillo, T.B.
  14. Al-Ali, H.K.
  15. Martinelli, G.
  16. Falantes, J.
  17. Noppeney, R.
  18. Stone, R.M.
  19. Minden, M.D.
  20. McIntyre, H.
  21. Songer, S.
  22. Lucy, L.M.
  23. Beach, C.L.
  24. Döhner, H.
Revue:
Blood

ISSN: 1528-0020,  0006-4971

Année de publication: 2015

Volumen: 126

Número: 3

Pages: 291-299

Type: Article

DOI: 10.1182/BLOOD-2015-01-621664 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus